🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

EP lab team in KBC Split- FIH series of point by point PVI using PFA through solid tip catheter and contact force sensing

Posterior wall isolation is a legal target for beyond PVI strategy in order to gain control over persistent AF. In this case PWI was achieved using pulsed field ablation delivered through the focal, solid tip ,commercially availabl…lnkd.in/gBBSUXA lnkd.in/g-egs6g

"Comparison of procedural efficacy, balloon nadir temperature and incidence of phrenic nerve palsy between two cryoballoon technologies for pulmonary vein isolation: a systematic review and meta‐analys" — Read it on ResearchGate: researchgate.net/publication/35…

Cryoballoon seems to beat HPSD in terms of procedural duration and reproducibility. However, 2 hours of mean procedure duration is way too much when compared what high volume EP labs report

How symbolic. KBC Split EP team performed today it’s first procedure in a new EP lab. It was a pulsed field ablation (Farapulse platform) for a patient with persistent AF despite durable PVI. Next chapter for our team start here!!!!

Proud to present PVI durability data for the focal PFA as late breaker clinical trial at HRS 2022. ECLIPSE AF trial was performed throughout the COVID pandemic which makes this achievement even greater.

What’s your approach? Patient with persistent LAA thrombus despite OAC. #EPLuebeck approach will follow tomorrow. Christian Sohns Prof. Dr. med. Alexander Pott Dominik Linz Dr. Helmut Pürerfellner Martin Manninger Arian Sultan Julian Chun Prash Sanders AGEP

lnkd.in/egrQ9HaX Great cases - unresolved topic! EHRA survey on such malignant LAA - AF and Stroke Prevention! Please share your thoughts here..!! 😉

We do care about messages from AF guidelines!! Now let’s talk if there are any messages we do not follow… Help EHRA Scientific Initiative Committee effort by filling in this survey surveymonkey.com/r/Current_mgt_…

This is important work and much needed for our understanding of lesion volume when ablating VAs in structural heart disease patients. Congrats Elad and the team!

Durable PVI with PFA is strong anti AF tool. Soon to publish 1 year clinical outcomes for the cohort of AF patients that was exclusively treated with focal PFA. Still don’t believe in PFA for AF story? You better start!!!

Fool room at FAFA 2023, #Maxim Didenko showing common obstacles to the transmural lesions and AF ablation success. Knowing anatomy and choosing the right tool to make safe, durable and transmural lesion is a key!!

Our team at KBC Split is continuing to explore safety and feasibility of focal PFA for transcoronary sinus ablation. Accessory pathway RF ablation at MCV ostial region is particularly troublesome for several reasons (coronary artery damage, high impedance preventing (safe) RFA

First in human implants of Future Cardia ILR had been performed at KBC Split this week. Great sensing capabilities that will go well beyond simple heart rhythm monitoring!! Heart failure patients could benefit from continuous monitoring for the early signs of decompensation

heartrhythmjournal.com/article/S1547-… Check out the paper on using focal PFA to treat accessory pathways. KBC Split EP team is using this as a preferred way of AP ablation. Vicinity to a conduction system remains main limitation. There are tips and tricks to learn…

Did you know that the EHRA Ablation Innovation Summit 2025 is happening just a day before #EHRA2025? 🔥 📍 29 March 2025 | 08:30 – 17:30 CET | Messe Wien, Austria 🔬 Dive into the latest AF ablation innovations, with a special focus on PFA, and explore cutting-edge advancements

Speaking soon at a live webinar on the future of #AFablation with #PFA technology. Join experts sharing real-world insights, clinical workflows, and mapping strategies. Register here: bostonsci.co/Ij6AsnaH7Sb #Epeeps #Cardiology